T1	Participants 93 124	people with multiple sclerosis.
T2	Participants 216 246	people with multiple sclerosis
T3	Participants 503 527	phase 1, 36 participants
T4	Participants 590 616	phase 2, the control group
T5	Participants 1067 1074	phase 1
T6	Participants 1120 1127	phase 2
T7	Participants 1223 1239	People with BBTW
T8	Participants 1658 1693	people with multiple sclerosis (MS)
